Jourr~ol of' Chromatography. 279 (1983) Several assays have been described for routine pharmacokinetic studies on unchanged CP and 5-FU. S-FU can be determined by means of gas chromatography2 and high-performance liquid chromatography3, whereas for CP gas chromatography is mostly preferred4. As CP and 5-FU are often administered in a combined therapy, it seemed worthwhile to develop an assay for the determination of CP and 5-FU in one analysis. Moreover, both CP and 5-FU are intensively metabolized, and pharmacological studies today generally require information about metabolism too. This new assay should also permit the determination of metabolites of CP and 5-FU. The new antitumour drug 5-DFUR is metabolized by thymidine phosphorylase (in man) and by uridine phosphorylase (in small animals) to 5-FU. 5-DFUR is now used in clinical trials in single-agent therapy; the determination of 5-DFUR, 5-FU and 5-fluorodihydrouracil (FDHU) appears to be of interest in following the pharmacokinetics of single-agent therapy.
EXPERIMENTAL CP, 4-ketocyclophosphamide (4-KCP), carboxyphosphamide (CCP), 4-hydroxycyclophosphamide (4-HPCP) and iphosphamide (IP) as reference substances were kindly supplied by ASTA-Werke (Bielefeld, F.R.G.). 5-FU, FDHU and 5-DFUR were gifts from Hoffmann-La Roche (Mijdrecht, The Netherlands) and 5-chlorouracil (5-CU, internal standard) from Calbiochem (Los Angeles. CA, U.S.A.).
Extr'uction of phsma snrnp!es
To 50 ~1 of human or rat plasma in a polythene tube, 500 ~1 of a mixture of 2propanol-diethyl ether (22:77) and 5-CU as internal standard were added. During mixing on Vortex mixer (5 min), 50 ~1 of acetone were added gradually to the mixture. After centrifugation for 5 min at 1000 g, the monolayer liquid phase was transferred into a second tube, which was placed at 291'K under a gentle stream ofnitrogen.
The residue was dissolved in 100 ~1 of 2-propanol-diethyl ether (22:77) and 10 ill of the solution were transferred to the stainless-steel needle of the solid-sample injector. All handling was carried out with protection against light as far as possible. If only 5-FU, FDHU and 5-CU must be determined, pre-extraction with chloroform can be used in order to remove interfering compounds, followed by the extraction of 5-FU, FDHU and 5-CU with ethyl acetate'.
Appuratus
Two gas chromatographs were used: a Packard Becker Model 420 (Packard Becker, Delft, The Netherlands), equipped with a Model 18-789 A nitrogenphosphorus selective detector (Hewlett-Packard, Avondale, PA, U.S.A.), and a Hewlett-Packard Model 5713A, equipped with a 63Ni pulse-modified electron-capture detector. The samples were introduced by means of a solid-sample injection system.
Support-coated
open-tubular (SCOT) OV-275 columns (10 or 7 m x 0.4 mm I.D. and 10 or 7 m x 0.31 mm I.D.), made of Duran 50 glass, were prepared as described in the literature".
Tempertxtures
Unless a temperature programme was used, the oven temperature was set at 478°K for the determination of all compounds mentioned.
The injection-port temperature was set at 328°K and the detector temperatures were 573°K (nitrogenphosphorus selective detector) and 623°K (electron-capture detector). The plasma concentrations were calculated by means of calibration graphs, obtained by analysing blank plasma samples spiked with known amounts of the compounds of interest. 5-CU was used as an internal standard.
Blood samples were collected in heparinized polythene tubes, taken at certain time intervals before and after starting the treatment. The samples were centrifuged at 1000 g within 1 h after collection, and then the plasma was taken off and stored at 258°K until analysed. The detection limit for 4-KCP is relatively unfavourable, owing to its anomalous chromatographic behaviour. This effect may be accounted for by the keto-enol equilibrium, which has been confirmed by gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry experiments.
The retention times of 5-FU and 5-CU can be shortened by using a temperature programme ( Fig. 3 ) resulting in analysis times of less than 12 min for all compounds.
In the same system compounds related to CP such as iphosphamide can be chromatographed.
The assay for the determination of CP, 5-FU and some metabolites, based on the 2-propanol diethyl ether extraction, was applied to monitoring CP, 4-KCP, CCP, -min min Fig. 3 . Chromatogram of the test mixture. Temperature: programmed from 478 to 493'K at Z'K/min. Temperature programme started 6 set after injection.
5-FU and FDHU plasma concentrations
of a WAG/Rij rat that had received CP and 5-FU intravenously (Fig. 4a ), the determination of CP, 5-FU and FDHU in the plasma of a patient treated with CP and 5-FU ( Fig. 4b ) and the determination of 5-FU and FDHU in the plasma of a patient treated with 5-DFUR ( Fig. 4~ ). It can be concluded that the nitrogen-phosphorus selective detector is the most suitable for monitoring all substances, because of the relatively large linearity. However, when measurements of 5-FU and FDHU between 1 and 50 ng/ml plasma are necessary, electron-capture detection must be applied. 
